Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies
![August 28, 2017 | Gilead Sciences to Acquire Kite Pharma for $11.9 Billion | California NanoSystems Institute August 28, 2017 | Gilead Sciences to Acquire Kite Pharma for $11.9 Billion | California NanoSystems Institute](https://cnsi.ucla.edu/wp-content/uploads/2019/02/kite-lab-800x600.jpg)
August 28, 2017 | Gilead Sciences to Acquire Kite Pharma for $11.9 Billion | California NanoSystems Institute
![Gilead Buys Santa Monica's Kite Pharma in $12 Billion Cancer-Drug Deal - Los Angeles Business Journal Gilead Buys Santa Monica's Kite Pharma in $12 Billion Cancer-Drug Deal - Los Angeles Business Journal](https://images.labusinessjournal.com/wp-content/uploads/2021/11/20160726RC.Kite003.jpg)